Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Avadel Pharmaceuticals (AVDL) has a market cap of $0.77 billion USD. According to our data, Avadel Pharmaceuticals is ranked No.5574 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $0.77 B |
-23.88%
|
| Dec 31, 2024 | $1.01 B |
-25.57%
|
| Dec 29, 2023 | $1.36 B |
97.21%
|
| Dec 30, 2022 | $0.69 B |
-11.39%
|
| Dec 31, 2021 | $0.78 B |
20.96%
|
| Dec 31, 2020 | $0.64 B |
-11.52%
|
| Dec 31, 2019 | $0.73 B |
192.64%
|
| Dec 31, 2018 | $0.25 B |
-68.54%
|
| Dec 29, 2017 | $0.79 B |
-21.08%
|
| Dec 30, 2016 | $1.00 B |
-14.91%
|
| Dec 31, 2015 | $1.18 B |
-28.72%
|
| Dec 31, 2014 | $1.65 B |
112.80%
|
| Dec 31, 2013 | $0.78 B |
165.68%
|
| Dec 31, 2012 | $0.29 B |
-41.84%
|
| Dec 30, 2011 | $0.50 B |
-23.83%
|
| Dec 31, 2010 | $0.66 B |
-7.57%
|
| Dec 31, 2009 | $0.71 B |
88.78%
|
| Dec 31, 2008 | $0.38 B |
-60.72%
|
| Dec 31, 2007 | $0.96 B |
-66.68%
|
| Dec 29, 2006 | $2.89 B |
58.63%
|
| Dec 30, 2005 | $1.82 B |
-3.13%
|
| Dec 31, 2004 | $1.88 B |
-27.25%
|
| Dec 31, 2003 | $2.58 B |
515.86%
|
| Dec 31, 2002 | $0.42 B |
59.93%
|
| Dec 31, 2001 | $0.26 B |
-62.48%
|
| Dec 29, 2000 | $0.70 B |
241.18%
|
| Dec 31, 1999 | $0.20 B |
-51.43%
|
| Dec 31, 1998 | $0.42 B |
141.38%
|
| Dec 31, 1997 | $0.17 B |
-75.83%
|
| Dec 31, 1996 | $0.72 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Jazz Pharmaceuticals
JAZZ
|
$7.31 B |
0.000 M
|
Ireland
|
 Supernus Pharmaceuticals
SUPN
|
$2.11 B |
-0.000 M
|
USA
|
 Axsome Therapeutics
AXSM
|
$4.96 B |
0.000 M
|
USA
|
 Ironwood Pharmaceuticals
IRWD
|
$0.60 B |
0.000 M
|
USA
|
 Collegium Pharmaceutical
COLL
|
$1.05 B |
0.000 M
|
USA
|
 Corcept Therapeutics
CORT
|
$6.18 B |
0.000 M
|
USA
|
 Amphastar Pharmaceuticals
AMPH
|
$1.74 B |
0.000 M
|
USA
|
 Pacira Biosciences
PCRX
|
$1.04 B |
-0.000 M
|
USA
|
 Eagle Pharmaceuticals
EGRX
|
$9.72 M |
0.000 M
|
USA
|
 ANI Pharmaceuticals
ANIP
|
$1.22 B |
0.000 M
|
USA
|
 Assertio Therapeutics
ASRT
|
$77.34 M |
-0.000 M
|
USA
|
 Perrigo
PRGO
|
$3.28 B |
0.000 M
|
Ireland
|
| Market Cap | = | AVDL Stock Price | * | AVDL Shares Outstanding |
| = | $8.00 | * | 96.36 M | |
| = | $0.77 B |